2,3,4-Trihydroxy-benzaldehyd-(4-nitro-phenylimin) | 100382-30-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2,3,4-Trihydroxy-benzaldehyd-(4-nitro-phenylimin)
• 英文别名: 4-[(4-Nitro-phenylimino)-methyl]-pyrogallol
• CAS: 100382-30-7
• 化学式: C₁₃H₁₀N₂O₅
• 分子量: 274.233
• InChiKey: FFQYKUXCDFBQJP-VGOFMYFVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.46
• 重原子数：
  20.0
• 可旋转键数：
  3.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  116.19
• 氢给体数：
  3.0
• 氢受体数：
  6.0

反应信息

• 作为产物：
  描述：

  2,3,4-三羟基苯甲醛 、 4-硝基苯胺 在 乙醇 作用下， 生成 2,3,4-Trihydroxy-benzaldehyd-(4-nitro-phenylimin)
  参考文献：
  名称：

  Capturing error rates and reporting significant data

  摘要：

  Programs that embrace sound outcomes, process, and structure assessment complemented by systematic inquiry and improvement serve as protectors of quality during an era of dramatic cost reduction. Outcome data presented alongside process and structural methods enable a clear understanding of quality, balancing the scales between societal cost and individual health. The ability to change a system through the generation and use of powerful data reporting mechanisms takes on increased significance as we strive to improve the safety of US health care. The NQF's work is just the tip of the iceberg; health care organizations must accept the inevitable: Practice standardization and delineation of concrete, nationwide quality benchmarks are the future of US health care.

  DOI：

  10.1016/s0899-5885(02)00016-3